GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Curiox Biosystems Co Ltd (XKRX:445680) » Definitions » Capex-to-Operating-Cash-Flow

Curiox Biosystems Co (XKRX:445680) Capex-to-Operating-Cash-Flow : 0.00 (As of Mar. 2025)


View and export this data going back to 2023. Start your Free Trial

What is Curiox Biosystems Co Capex-to-Operating-Cash-Flow?

Capex-to-Operating-Cash-Flow assesses how much of a company’s cash flow from operations is being devoted to capital expenditure. It’s also useful to distinguish whether the company is capital intensive or not.

Curiox Biosystems Co's Capital Expenditure for the three months ended in Mar. 2025 was ₩-9.82 Mil. Its Cash Flow from Operations for the three months ended in Mar. 2025 was ₩-3,214.09 Mil.

GuruFocus do not calculate Capex-to-Operating-Cash-Flow if the Cash Flow from Operations is negative.


Curiox Biosystems Co Capex-to-Operating-Cash-Flow Historical Data

The historical data trend for Curiox Biosystems Co's Capex-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curiox Biosystems Co Capex-to-Operating-Cash-Flow Chart

Curiox Biosystems Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Capex-to-Operating-Cash-Flow
Get a 7-Day Free Trial - - - - -

Curiox Biosystems Co Quarterly Data
Dec19 Dec20 Dec21 Mar22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Capex-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Curiox Biosystems Co's Capex-to-Operating-Cash-Flow

For the Medical Devices subindustry, Curiox Biosystems Co's Capex-to-Operating-Cash-Flow, along with its competitors' market caps and Capex-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Curiox Biosystems Co's Capex-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Curiox Biosystems Co's Capex-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Curiox Biosystems Co's Capex-to-Operating-Cash-Flow falls into.


;
;

Curiox Biosystems Co Capex-to-Operating-Cash-Flow Calculation

Curiox Biosystems Co's Capex-to-Operating-Cash-Flow for the fiscal year that ended in Dec. 2024 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (-257.879) / -9698.165
=N/A

Curiox Biosystems Co's Capex-to-Operating-Cash-Flow for the quarter that ended in Mar. 2025 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (-9.821) / -3214.09
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Curiox Biosystems Co  (XKRX:445680) Capex-to-Operating-Cash-Flow Explanation

Capex-to-Operating-Cash-Flow ratio assesses how much of a company’s Cash Flow from Operations is being devoted to Capital Expenditure. It is a good indicator in terms of how much the company is focused on growth. In general, a high Capex-to-Operating-Cash-Flow ratio indicates that the company is investing more in physical assets and is focused on growth and expansion. Conversely, lower ratio could indicate that a company has reached maturity and is no longer pursuing aggressive growth.

Moreover, the ratio is also useful to distinguish whether the company is capital intensive or not. If the ratio is large, then the company tends to be capital intensive. Lower ratio suggests that it’s a capital-light business. The ratio can be combined with ROIC % to identify whether the company is an asset-light business that has a high return on invested capital. This is one question investors commonly ask to see if a company qualifies as a good company.


Curiox Biosystems Co Capex-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Curiox Biosystems Co's Capex-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Curiox Biosystems Co Business Description

Traded in Other Exchanges
N/A
Address
Samsung Harrington IT Tower, 204-213, 202, 2nd Floor, 9 Gil 41 Digital-Ro, Geumchun-Gu, Seoul, KOR, 08511
Curiox Biosystems Co Ltd is Korean Based company which brings together decades of scientific and engineering expertise in surface chemistry and life science instrumentation with the goal of overcoming critical challenges that slow the pace of life science research. The company has introduced Laminar Wash technology, which automates cell processing and enables highly reproducible and high-throughput cell analysis. The company offers various products such as LAMINAR WASH AUTO 1000 SYSTEM, Curiox Laminar Wash HT2000 System and Laminar Wash MINI System.

Curiox Biosystems Co Headlines

No Headlines